clima-header

Buenos Aires - - Monday 08 De March

Home Argentine Knowledge Modifying DNA to Avoid Diseases: The Challenge of Gene Editing in Argentina

Modifying DNA to Avoid Diseases: The Challenge of Gene Editing in Argentina

Avoiding diseases such as diabetes, Alzheimer's and cardiac arrhythmia that causes sudden death are some of the projects in which pioneering Argentine scientists work in the country and the region.

Knowledge
Modificar el adn para evitar enfermedades: el desafío de la edición génica en Argentina

Editing or “correcting” genes to avoid diseases such as diabetes, Alzheimer's and cardiac arrhythmia that causes sudden death are some of the projects in which pioneering Argentine scientists work in the country and the region, which assure that “a gene repaired with molecular scissors can not differentiate from a healthy one”. “Gene editing applied in  medicine  is a biotechnology that allows us to repair a gene with great precision. How great is that precision? So big that it leaves no traces: a repaired gene cannot be differentiated from a healthy original gene,” said Télam Federico Pereyra Bonnet, researcher at   Conicet  and the Unit of Molecular Medicine and Genomics of the Italian Hospital. The specialist explained that gene editing can also “knock out a gene”, that is, cancel it if it is malfunctioning or if its presence exposes the person to contracting a disease. “Another of the qualities of this technology is its low cost: using CRISPR (molecular scissors that were recently discovered in bacteria), is hundreds of times cheaper than working with previous technologies,” he stressed.

Pereyra Bonnet noted that although this technique has great potential, it is still in experimental phase and “was not tested in patients.” “Several local groups quickly grasped the enormous potential of gene editing to impact human health and pioneered their research in the country and the region. Today we have several examples of groups working with CRISPR studying new treatments,” he said. The doctor and scientist highlighted four projects: at the Rosario Institute of Molecular and Cellular Biology, a team of researchers work editing the gene that produces Treacher Collins Syndrome, which causes craniofacial malformations that can only be corrected by surgeries. In addition, a team from the Foundation for the Fight against Neurological Diseases of Childhood (Fleni) works in Buenos Aires to correct two genes that produce cardiac arrhythmogeny, a heart disease primarily responsible for sudden death in young athletes.

In the UBA School of Medicine, while gene editing is investigating the role of the motor proteins of neurons during the onset and advancement of Alzheimer's and Parkinson's, while the Pereyra Bonnet team uses CRISPR to activate the insulin gene in cell cultures of patients with diabetes. “Internationally, only a handful of clinical trials are beginning to recruit patients to test this technology, but they have not yet started. The focus is mainly on knowing more about the system and registering how safe and effective it is,” said the expert. Fabiana Arzuaga, coordinator of the Interministerial Commission on Advanced Therapies, said in dialogue with this agency that changes to  DNA  sequences can be carried out in somatic cells, differentiated ones that form the human body, or germ cells, which give rise to a new individual (sperm, egg, zygote and early  embryo  ). “In the first case the edited cells are introduced into the patient's body as a treatment and the modified DNA does not move to future generations, disappears with that patient,” explained the lawyer. Instead, when germ cells that will give rise to a human being are edited, that modification “can produce changes in DNA that can be inherited by later generations.”

The therapeutic use of germline modification “is not approved in Argentina or in the rest of the world. There are only a few investigations and they are very controlled. One example is the case of the United Kingdom, where the research protocol must be approved by the Human Fertilization and Embryology Authority, but in no case could these embryos be implanted in a woman's womb, but should be destroyed once the research is complete,” he said. or. Thus, most of the ongoing research and clinical trials are in somatic cells and regulated as Advanced Therapies Medicines by the world's leading health agencies. “Argentina has a regulatory framework recently created by the Interministerial Commission on Research and Medicines of Advanced Therapy, which includes Anmat and Incucai standards to regulate the use of cells and tissues,” said Arzuaga.

Source: Telam

Publication Date: 17/12/2018

Share
Rate this item
0/5

Te sugerimos continuar leyendo las siguientes notas:

Silvio-Gutkind An Argentine doctor is distinguished as a member of the National Academy of Medicine of the United States
Myths and truths of a treatment that revolutionized aesthetic medicine

Topics

cat1-artículos

I wrote! Reader Notes

Go to section

Comments


There are not comments

Leave feedback


Comments

History
Eduarda Mansilla Eduarda Mansilla's silent revolution

A pioneer of Argentine journalism and fantasy, her controversial writings return in the years of the...

The worst thing about us
7 cordobesas menos 8M: 7 Cordobese less

In just 70 days of 2021, we are missing 7 Cordovan women who were bloody murdered by the hands of vi...

Knowledge
Gina Antonella Tonicelli The contribution of a scientist from General Roca

The young Gina Antonella Tonicelli began her doctoral studies in biology on seaweed from Piedras Col...

Knowledge
Romina Carranza The comodorense who created a blueprint for non-seers

Romina Carranza is a biomedical engineer and created a device for non-seers: a haptic plan of the pr...

fm-barcelona

Articles


I want to be up to date

Subscribe to our newsletter and I received the latest news